Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Dividenden-Strategie | 9 / 15 |
HGI-Strategie | 18 / 18 |
Levermann-Strategie | -5 / 13 |
News
5 Best CEFs This Month For Yields Up To 15% (June 2025)
For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone. In this monthly series, we highlight five CEFs with solid track records that pay high distributions and offer "excess" discounts. We try to separate the wheat from the chaff using our filtering process to select just five CEFs every month from around 500 closed-end funds.» Mehr auf seekingalpha.com
Dividend Harvesting Portfolio Week 224: $22,400 Allocated, $2,349.12 In Projected Dividends
Despite a market pullback, my Dividend Harvesting Portfolio delivered positive returns and increased income, showcasing the benefits of diversification and disciplined reinvestment. I added to VICI, NNN, BSTZ, and MSTY, targeting high-yield, stable, and discounted assets poised to benefit from future Fed rate cuts and sector trends. The portfolio's forward dividend income and YoY growth remain strong, with reinvestment and sector allocation driving compounding income and downside risk mitigation.» Mehr auf seekingalpha.com
5 Closed-End Fund Buys In The Month Of May 2025
The market saw a strong continuing recovery in May from April's market drop. The rebound was enough to see the drop recover entirely that was seen in April, but the markets still remain off all-time highs seen in February. While there wasn't as much in terms of opportunity for buying as there was in April, I add to my CEF positions every month regardless.» Mehr auf seekingalpha.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
(EUR) | Dez. 2024 | |
---|---|---|
Umsatz | 91,89 Mio | - |
Bruttoeinkommen | 80,60 Mio | - |
Nettoeinkommen | 111,61 Mio | - |
EBITDA | 111,72 Mio | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 1,23 Mrd€ |
Anzahl Aktien | 70,51 Mio |
52 Wochen-Hoch/Tief | 18,91€ - 12,92€ |
Dividendenrendite | 13,72% |
Dividenden TTM | 2,40€ |
Nächste Dividende | 0,18€ |
Beta | 1,52 |
KGV (PE Ratio) | 4,90 |
KGWV (PEG Ratio) | 3,79 |
KBV (PB Ratio) | 0,97 |
KUV (PS Ratio) | 25,00 |
Unternehmensprofil
BlackRock Science and Technology Trust II, ehemals Blackrock Science & Technology Trust Ii, ist ein nicht-diversifizierter, geschlossener Aktienfonds. Das Anlageziel der Gesellschaft besteht darin, durch eine Kombination aus Erträgen, Gewinnen und langfristigem Kapitalzuwachs eine Gesamtrendite und Erträge zu erzielen. Der Trust investiert mindestens 80 % seines Gesamtvermögens in Aktienwerte, die von US-amerikanischen und nicht-amerikanischen Wissenschafts- und Technologieunternehmen beliebiger Marktkapitalisierung ausgegeben werden. BlackRock Advisors, LLC ist der Anlageberater des Trusts.
Name | BLACKROCK SC.+TECH. TR.II |
CEO | John M. Perlowski |
Sitz | New York City, ny USA |
Website | |
Börsengang | |
Mitarbeiter | 0 |
Ticker Symbole
Börse | Symbol |
---|---|
NYSE | BSTZ |
Assets entdecken
Shareholder von BLACKROCK SC.+TECH. TR.II investieren auch in folgende Assets